NCT07180069

Brief Summary

Raised phosphate levels in the blood (hyperphosphatemia) are frequently observed in hemodialysis patients with chronic kidney failure. In addition to increasing the risk of life threatening complications like heart disease, severe bone disorders, and premature mortality, this condition also poses risks to overall health. Managing phosphate levels effectively is one of the central objectives in treating patients on dialysis. Control of dietary intake, particularly cutting out high phosphate foods, is one of the most effective ways of managing phosphate levels. Dietary restrictions can be challenging for most patients to adhere to, and effective educational tools for assisting them remain unclear. This clinical study aims to evaluate the impact of diet-derived education aimed solely at reducing phosphate levels in blood. Patients undergoing hemodialysis at a dialysis center will be randomly assigned to one of two groups. In addition to standard dietary advice, one group will receive targeted phosphate-specific dietary education which includes personalized counseling and aids to encourage selection of low-phosphate foods. The primary objective is to determine whether participants in the phosphate-specific education group achieve a greater reduction in blood phosphate levels over time as compared to those who receive standard care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2025

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

July 20, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

September 18, 2025

Completed
Last Updated

September 18, 2025

Status Verified

September 1, 2025

Enrollment Period

3 months

First QC Date

July 20, 2025

Last Update Submit

September 11, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in serum phosphate concentration measured by standard blood test (mg/dL)

    The primary outcome is the change in serum phosphate level from baseline to 12 weeks. Serum phosphate will be measured using venous blood samples and analyzed with an automated chemistry analyzer in the hospital laboratory.

    Baseline and at weeks 4,8 and week 12

Study Arms (2)

Standard Dietary Advice"

NO INTERVENTION

Routine general dietary advice for hemodialysis patients, not phosphate-focused.

Phosphate-Specific Dietary Education

OTHER

Individualized dietary education focused on reducing phosphate intake (food choices, portion control, additives).

Other: diet education

Interventions

Individualized dietary education focused on reducing phosphate intake (food choices, portion control, additives).

Phosphate-Specific Dietary Education

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Males and females aged 18-60 years
  • Stage 5 CKD patients on hemodialysis
  • Receiving ≥2 weekly dialysis sessions for ≥2 months
  • Written informed consent provided
  • Ability (patient/caregiver) to read, write, and speak Arabic

You may not qualify if:

  • Age \<18 or \>60
  • Receiving \<2 dialysis sessions per week or \<2 months duration
  • Refusal or inability to provide consent
  • Severe mental illness or cognitive impairment
  • Acute illness, infection, or hospitalization at enrollment
  • Malabsorption conditions or prior GI surgery
  • Noncompliance with medication or dialysis regimen

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of kufa

Najaf, 24001, Iraq

Location

MeSH Terms

Conditions

Hyperphosphatemia

Interventions

Nutrition Assessment

Condition Hierarchy (Ancestors)

Phosphorus Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationEpidemiologic MeasurementsPublic HealthEnvironment and Public Health

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

July 20, 2025

First Posted

September 18, 2025

Study Start

October 1, 2024

Primary Completion

January 1, 2025

Study Completion

January 1, 2025

Last Updated

September 18, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL

Locations